Zai Lab Announces Acceptance of New Drug Application for KarXT for the Treatment of Schizophrenia
Jan 17, 2025
Read MoreZai Lab Announces Positive Topline Results for TIVDAK in the China Subpopulation of the Global Phase 3 innovaTV 301 Trial in Patients with Recurrent or Metastatic Cervical Cancer
Jan 15, 2025
Read MoreZai Lab and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan region and Singapore
Jan 10, 2025
Read MoreZai Lab Announces Strategic Partnership with MediLink Therapeutics to Develop a Novel LRRC15 Antibody-Drug Conjugate
Jan 09, 2025
Read More